Decibel Therapeutics Inc.

NASDAQ: DBTX · Real-Time Price · USD
4.91
-0.04 (-0.81%)
At close: Sep 22, 2023, 10:00 PM

Decibel Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-63.01M -51.82M
Depreciation & Amortization
1.46M 1.41M
Stock-Based Compensation
3.2M 2.82M
Other Working Capital
-8.89M 8.8M
Other Non-Cash Items
2.06M 952K
Deferred Income Tax
n/a n/a
Change in Working Capital
-618K 3.49M
Operating Cash Flow
-56.9M -43.15M
Capital Expenditures
-463K -745K
Cash Acquisitions
n/a n/a
Purchase of Investments
-97.51M -197.46M
Sales Maturities Of Investments
153.07M 97.07M
Other Investing Acitivies
n/a 139K
Investing Cash Flow
55.1M -101M
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a -1K
Dividend Paid
n/a n/a
Other Financial Acitivies
-213K 152.51M
Financial Cash Flow
-213K 152.51M
Net Cash Flow
-2.01M 8.37M
Free Cash Flow
-57.36M -43.9M